Ceevra Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $10M

  • Investors
  • 18

Ceevra General Information

Description

Developer of an artificial intelligence software designed to utilize machine learning and computer vision to generate interactive patient-specific 3D digital models from existing CT scans and MRIs. The company's technology generates 3D digital models that are viewed by surgeons from their mobile devices, computers, or through robotic surgical systems for preoperative planning, patient counseling, and intraoperative decision-making and gain important insights while operating on a patient.

Contact Information

Website
www.ceevra.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Surgical Devices
Corporate Office
  • 149 New Montgomery Street
  • 4th Floor
  • San Francisco, CA 94105
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ceevra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series A) $10M Upcoming Generating Revenue
6. Early Stage VC 01-Jun-2021 0000 000.00 Completed Generating Revenue
5. Seed Round 01-Apr-2020 00000 00.000 Completed Generating Revenue
4. Seed Round 30-Aug-2019 00000 00.00 Completed Generating Revenue
3. Seed Round 30-Jun-2018 00000 00.00 Completed Generating Revenue
2. Seed Round 26-Dec-2017 $650K $1.2M Completed Generating Revenue
1. Seed Round 31-Mar-2017 $550K $550K Completed Generating Revenue
To view Ceevra’s complete valuation and funding history, request access »

Ceevra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 1D 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 1C 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed 1B 1,567,917 $0.000100 $0.47 $0.47 1x $0.47 13.78%
Seed 1A 2,774,761 $0.000100 $0.24 $0.24 1x $0.24 24.39%
To view Ceevra’s complete cap table history, request access »

Ceevra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence software designed to utilize machine learning and computer vision to generate in
Decision/Risk Analysis
San Francisco, CA
13 As of 2024
000.00
000000 0

000000

t. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
00000 0000000000 000
Strasbourg, France
00 As of 0000
0000
000.00 0000-00-00
0000000000 0 0000

000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
00000 0000000000 000
Newark, CA
00 As of 0000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ceevra Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Visible Patient Venture Capital-Backed Strasbourg, France 00 0000 0000000000 0 0000
Ziosoft Corporate Backed or Acquired Newark, CA 00 000000&0
Materialise Formerly VC-backed Leuven, Belgium 0000 00000 00000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Ceevra Patents

Ceevra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11348250-B2 Image analysis system for identifying lung features Active 11-Nov-2019 00000000 0
US-20210142485-A1 Image analysis system for identifying lung features Active 11-Nov-2019 00000000
US-20220237805-A1 Image analysis system for identifying lung features Pending 11-Nov-2019 00000000 0
EP-4058982-A1 Image analysis system for identifying lung features Pending 11-Nov-2019 00000000
EP-4058982-A4 Image analysis system for identifying lung features Pending 11-Nov-2019 G06T7/11 0
To view Ceevra’s complete patent history, request access »

Ceevra Executive Team (5)

Name Title Board Seat Contact Info
Russ Yoshinaka Co-Founder & Chief Executive Officer
Ken Koster Co-Founder and Chief Technology Officer
Tim Wern Chief Commercial Officer
Joseph Shirk MD Co-Founder and Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Ceevra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ceevra Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kerry Champion Angel (individual) Minority 000 0000 000000 0
Ben Smith Angel (individual) Minority 000 0000 000000 0
Camille Germanos Angel (individual) Minority 000 0000 000000 0
Farzad Nazem Angel (individual) Minority 000 0000 000000 0
Henry Kravis Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Ceevra FAQs

  • When was Ceevra founded?

    Ceevra was founded in 2016.

  • Who is the founder of Ceevra?

    Russ Yoshinaka, Ken Koster, and Joseph Shirk MD are the founders of Ceevra.

  • Who is the CEO of Ceevra?

    Russ Yoshinaka is the CEO of Ceevra.

  • Where is Ceevra headquartered?

    Ceevra is headquartered in San Francisco, CA.

  • What is the size of Ceevra?

    Ceevra has 13 total employees.

  • What industry is Ceevra in?

    Ceevra’s primary industry is Decision/Risk Analysis.

  • Is Ceevra a private or public company?

    Ceevra is a Private company.

  • What is Ceevra’s current revenue?

    The current revenue for Ceevra is 00000.

  • How much funding has Ceevra raised over time?

    Ceevra has raised $13.3M.

  • Who are Ceevra’s investors?

    Kerry Champion, Ben Smith, Camille Germanos, Farzad Nazem, and Henry Kravis are 5 of 18 investors who have invested in Ceevra.

  • Who are Ceevra’s competitors?

    Visible Patient, Ziosoft, and Materialise are competitors of Ceevra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »